Back

Association of inflammatory and oxidative markers with low voltage areas and atrial fibrillation recurrence in left atrial mapping

31 March 2025 (08:00 - 17:45)
Organised by: Logo
Congress Presentation Part of: Poster session 2: arrhythmia mechanisms, device therapy, and ventricular arrhythmias Catheter Ablation of Arrhythmias EHRA Premium Access EHRA 2025 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Nicola Pierucci

Hospital Clinic Barcelona, Barcelona (Spain)

146 More presentations in this session

Presentation thumbnail
Impact of ICD and CRT-D implantation on survival in ischemic and non-ischemic cardiomyopathy: a single-center croatian retrospective cohort study and comparative insights with the DANISH trial
Assistant Professor M. Puljevic (Zagreb, HR)
Abstract
Presentation thumbnail
Do the longer leadless pacemakers with helix screws affect tricuspid regurgitation after pacemaker implantation?
Presentation thumbnail
Classification of atrial fibrillation burden pattern in cardiac implantable electronic devices
Mr S. Majumder (Minneapolis, US)
Abstract Slides Video
Presentation thumbnail
Life-threatening arrhythmia in patients with suspected acute myocarditis
Miss K. Bulatova (Basel, CH)
Abstract Slides Video
Presentation thumbnail
Early outcomes of left bundle branch area pacing upgrade in pediatric pacing-induced cardiomyopathy
Mr Y. Turubayev (Astana, KZ)
Abstract Slides Video

Access the full session

Session thumbnail
Poster session 2: arrhythmia mechanisms, device therapy, and ventricular arrhythmias

The Event

Event poster

EHRA 2025

31 March 2025 08:00 CET
You may be interested in
thumbnail
Congress Presentation
Evaluation of oxidative stress biomarkers in patients undergoing catheter ablation for atrial fibrillation
thumbnail
Congress Presentation
Analysis of inflammatory and oxidative stress markers in radiofrequency and PFA for atrial fibrillation
thumbnail
Congress Presentation
Recurrence risk of atrial fibrillation in the 1-year post-ablation with radiofrequency in patients with high p wave dispersion and low voltage areas

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources